“a favorable trend”

Finally, from the simulation outcomes for delays, it can be concluded that the time taken for information to traverse from a source to a destination showcases a favorable trend with time, indicating an optimized and expedited data dissemination process.

The results indicated a favorable trend of relieving leucopenia when Shenqifuzheng + NP regimen, Shenmai + NP regimen, Shengmai + NP regimen, Shenfu + NP regimen, Kangai + NP regimen and Delisheng + NP regimen were applied.

SOD also showed a favorable trend (SMD = 1.02; 95% CI: −0.84 to 2.88), although with wide variability and a lack of statistical significance.

Moreover, interventions involving aerobic exercise and dietary restriction seemed to show a favorable trend concerning to WM. 4.1.

A favorable trend was seen for all pre-defined outcome variables which indicates that the lifestyle advice delivered via SMS may have contributed to the improvement.

In the ADAURA trial, patients with stage IB demonstrated a favorable trend in 5-year OS (94% vs 88%, hazard ratio [HR], 0.44; 95% CI, 0.17-1.02). 6 However, the magnitude and consistency of the benefit of adjuvant targeted therapy (ATT) in this subgroup remain ambiguous when compared with adjuvant chemotherapy (ACT) or placebo, particularly in terms of OS. 9 Emerging data

Since the results in humans for rhBMP-2 application for bone regeneration in MRONJ show a favorable trend, more studies with larger sample sizes, uniform methodology, and prolonged follow-up are required to confirm these findings.

The risk of death was substantially lower among patients with dMMR/MSI-H disease (HR 0.32; 95% CI 0.17–0.63), while a favorable trend toward improved overall survival was observed in the pMMR/MSS population (HR 0.79; 95% CI 0.60–1.04) ( Powell et al., 2024 ).

In the CKDB-322 group, triglyceride levels showed a favorable trend, decreasing by −17.48 ± 61.32 mg/dL, while the placebo group experienced an increase of 12.33 ± 53.06 mg/dL.

20.4) and a favorable trend in OS compared with those who continued systemic therapy alone, validating the role of surgery as a consolidative treatment in responders [ 107 ].

For Stage IC patients, those receiving chemotherapy ( n = 744) had a favorable trend in OS compared to those not receiving chemotherapy ( n = 145), with 5-year OS rates of 85.1% and 77.5%, although the difference was not statistically significant ( p =0.116).

Additionally, results indicate a favorable trend in reducing VAS-B scores.

The skewness and entropy AUCs exhibited a favorable trend in the intermediate energy range.

20 According to the hierarchical testing, OS was significantly improved with tislelizumab over chemotherapy in patients with PD-L1 TAP ≥ 10% (HR, 0.54), and in the prespecified exploratory analysis, tislelizumab also showed a favorable trend of improvement in OS versus chemotherapy in patients with PD-L1 TAP < 10% (HR, 0.82).

Individual studies comparing CC-Only CPR versus conventional CPR instructions with rescue ventilation show a favorable trend towards CC-Only CPR instructions [ 26 - 28 ].

Thus, a single-center study with a prospective cohort of 44 adult glioblastoma patients combined volumetric MRI-based extent-of-resection analysis with rapid PCR-based detection of TERT promoter mutation at the surgical margin and found that achieving an undetectable molecular margin was associated with significantly prolonged PFS and a favorable trend for OS [ 102 ].

Overall survival showed a favorable trend.

In another study on hospitalized COVID-19 patients, the percentage of hypertensive patients taking ACE-I/ARB did not differ between those with severe and non-severe infection or between non-survivors and survivors, with a favorable trend for ACE-I/ARB, although adjusted analysis was not performed [ 7 ].

In a recent, but smaller trial, involving 26 patients with acute ischemic stroke, ReIP showed a favorable trend toward improving clinical outcomes at 3 months as well as an increase in the circulating levels of a putative biomarker, heat shock protein-27 ( 14 ).

MFC-MRD–free survival showed a favorable trend in the maintenance group, although this did not reach statistical significance (2-year MFC-MRD–free survival: 85.5% [95% CI, 74.4–98.3] vs. 68.7% [95% CI, 57.3–82.4], p = 0.051).

In the CT cohort, subgroup analysis indicated a favorable trend of DFS for patients with KRAS / NRAS / BRAF mutations and receiving up to four cycles of conversion therapy ( P _interaction, 0.005 and 0.013, respectively).

Notably, while diarrhea and constipation showed a favorable trend in the probiotic group, the difference did not reach statistical significance, a finding also reported previously [ 49 ].

There was also a favorable trend with lower recurrence of gastric outlet obstruction in the EUS-GE group (3 %) as compared to the surgical group (14 %); although this was not statistically significant ( P = 0.08).

We found a favorable trend of better outcome in rt-PA treated patients, although the overall difference was not statistically significant (OR, 1.48; 95% CI, 0.91–2.43; P = 0.12).

22 While SGLT2i use was associated with a significantly lower risk, GLP-1RAs demonstrated a favorable trend (HR 0.86; 95% CI 0.73–1.01), narrowly missing statistical significance.